Protein kinase inhibitors are disclosed having utility in the treatment of protein kinase-mediated diseases and conditions, such as cancer. The first source has a first spectral output and the second source has a second spectral output different than the first spectral output. One technique includes operating an x-ray tube at elevated amperage.